Contraceptive steroids and coronary artery atherosclerosis in cynomolgus macaques.
The influence of two types of steroidal contraception on the extent of coronary, aortic, carotid, and iliaco-femoral atherosclerosis was assessed in 57 cynomolgus macaques with moderate diet-induced hyperlipoproteinemia. Thirteen animals were treated with an intravaginal ring that released 17 beta-estradiol and levonorgestrel. Fifteen females were treated with an oral contraceptive (OC) composed of ethinyl estradiol and norgestrel. Fifteen females received placebo vaginal rings, and 14 males were untreated. The contraceptive treatments resulted in similar large reductions in plasma high-density lipoprotein (HDL) cholesterol concentrations. Neither treatment influenced the prevalence of coronary artery atherosclerosis. However, treatment with the contraceptive vaginal ring was associated with increased extent of coronary artery atherosclerosis (plaque size) relative to untreated females, whereas treatment with the OC was not. The contrasting effects of the two treatments could not be explained by differences in total plasma cholesterol, HDL cholesterol, or blood pressure. The results suggest that the greater estrogenic influence associated with the ethinyl estradiol-containing OC resulted in inhibition of coronary artery atherosclerosis despite a pronounced progestin-induced lowering of plasma HDL cholesterol concentration and, further, that hormonal balance may have a marked influence on the relationship between plasma lipids and atherogenesis.
D000818:Animals; D001161:Arteriosclerosis / Q000139:chemically induced*; D001794:Blood Pressure; D008076:Cholesterol, HDL / Q000097:blood; D003271:Contraceptive Agents, Female / Q000633:toxicity*; D003278:Contraceptives, Oral, Hormonal / Q000633:toxicity*; D003324:Coronary Artery Disease / Q000139:chemically induced*; D004958:Estradiol / Q000008:administration & dosage / Q000097:blood; D005260:Female; D016912:Levonorgestrel; D008055:Lipids / Q000097:blood; D008074:Lipoproteins / Q000097:blood; D008075:Lipoproteins, HDL / Q000097:blood; D053439:Lipoproteins, HDL2; D008252:Macaca fascicularis; D008297:Male; D009644:Norgestrel / Q000008:administration & dosage / Q000097:blood
D008076:Cholesterol, HDL; D003271:Contraceptive Agents, Female; D003278:Contraceptives, Oral, Hormonal; D008055:Lipids; D008074:Lipoproteins; D008075:Lipoproteins, HDL; D053439:Lipoproteins, HDL2; D009644:Norgestrel; D004958:Estradiol; D016912:Levonorgestrel